Richard Scott Blackley Sells 25,135 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 25,135 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the transaction, the chief financial officer directly owned 1,351,034 shares in the company, valued at $22,413,654.06. The trade was a 1.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Oscar Health Price Performance

NYSE:OSCR traded up $0.07 during midday trading on Thursday, hitting $17.17. The company had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. The company has a market capitalization of $4.55 billion, a PE ratio of -15.33 and a beta of 1.88. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.80. The stock’s fifty day moving average price is $18.08 and its 200-day moving average price is $16.93.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm had revenue of $2.93 billion for the quarter, compared to analyst estimates of $3.09 billion. During the same quarter in the previous year, the firm posted ($0.22) EPS. The company’s revenue for the quarter was up 23.2% compared to the same quarter last year. As a group, research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of OSCR. IFP Advisors Inc increased its holdings in Oscar Health by 2,762.6% in the 3rd quarter. IFP Advisors Inc now owns 6,498 shares of the company’s stock valued at $123,000 after acquiring an additional 6,271 shares during the last quarter. Cantor Fitzgerald L. P. grew its position in shares of Oscar Health by 2.2% during the third quarter. Cantor Fitzgerald L. P. now owns 125,144 shares of the company’s stock valued at $2,369,000 after purchasing an additional 2,637 shares in the last quarter. CIBC Bancorp USA Inc. bought a new stake in shares of Oscar Health in the third quarter worth about $392,000. EMC Capital Management increased its holdings in shares of Oscar Health by 336.7% in the third quarter. EMC Capital Management now owns 13,100 shares of the company’s stock worth $248,000 after purchasing an additional 10,100 shares during the last quarter. Finally, Advisory Services Network LLC lifted its position in shares of Oscar Health by 390.1% in the third quarter. Advisory Services Network LLC now owns 39,235 shares of the company’s stock worth $743,000 after buying an additional 31,229 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on OSCR shares. Barclays raised their price objective on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a research report on Monday, November 10th. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. Wells Fargo & Company cut their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a report on Thursday, November 13th. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and raised their target price for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Finally, Wall Street Zen raised Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday, November 22nd. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of “Reduce” and a consensus target price of $14.86.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.